Study of the mechanisms of the modifying actions of hexamethonium on the cardiovascular response to norepinephrine.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D003714:Denervation; D004285:Dogs; D004357:Drug Synergism; D005260:Female; D005267:Femoral Nerve / Q000502:physiology; D006584:Hexamethonium Compounds / Q000494:pharmacology*; D006614:Hindlimb; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D012584:Sciatic Nerve / Q000502:physiology
D006584:Hexamethonium Compounds; D009638:Norepinephrine